Eli Lilly and Company
LLY
•Stock Analysis$775.45
+0.00 (+0.00%)• Live
Eli Lilly and Company Analysis Dashboard - Stock Analysis and Financial Metrics
Historical Prices
for Eli Lilly and Company
Key Financial Metrics
for Eli Lilly and Company
P/E Ratio
65.43
Revenue Growth
+32.00%
EPS Growth
+101.72%
Market Cap
$766.35B
Dividend Yield
+0.69%
Debt/Equity
2.44
ROIC
+25.72%
FCF Yield
+0.06%
View additional metrics
Valuation
P/B Ratio46.10
EV/Sales16.36
Financial Health
Current Ratio1.37
Return on Assets+14.31%
Analyst Recommendations
for Eli Lilly and Company
42 analysts
Consensus: Buy
About
for Eli Lilly and Company
Company Details
for Eli Lilly and Company
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
David A. Ricks
Employees
47,000
Market Cap
734.92B
Exchange
New York Stock Exchange
IPO Date
June 1, 1972
Website
www.lilly.comCIK
0000059478
ISIN
US5324571083
CUSIP
532457108
Country
US
Balance Sheet
for Eli Lilly and Company
Cash Flow Statement
for Eli Lilly and Company
Income Statement
for Eli Lilly and Company
News
No news available at the moment.